Clinical Trial Update: A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial evaluating GD2-targeted CAR T cells for neuroblastoma is currently in the recruiting stage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• GD2-CAR T cells

Snippet

Sponsor: The General Hospital of Western Theater Command | Conditions: Neuroblastoma | EARLY_Phase 1 | Status: RECRUITING